Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Plos One
|
April 5, 2018
Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells
Thomas Del'Guidice, Jean-Pascal Lepetit-Stoffaes, Louis-Jean Bordeleau, et al.
European Journal of Haematology
|
August 5, 2020
Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors
Jean-Sébastien Claveau, Sandra Cohen, Imran Ahmad, et al.
Leukemia
|
February 13, 2020
ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia
Denis Claude Roy, Irwin Walker, Johan Maertens, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2024
A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant
Richard LeBlanc, Stéphanie Thiant, Rafik Terra, et al.
Plos Medicine
|
March 24, 2007
Prediction of graft-versus-host disease in humans by donor gene-expression profiling
Chantal Baron, Roland Somogyi, Larry D Greller, et al.
Coronary Artery Disease
|
September 5, 2015
Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy
Fuyu Qiu, Akiko Maehara, Ramez El Khoury, et al.
Bone Marrow Transplantation
|
June 9, 2026
Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy
Stéphanie Thiant, Simon Dufresne, Imran Ahmad, et al.
Blood Advances
|
July 19, 2023
Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence
Sandra Cohen, Nadia Bambace, Imran Ahmad, et al.
British Journal of Haematology
|
May 29, 2019
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis
Denis Claude Roy, Sylvie Lachance, Sandra Cohen, et al.
Transplantation and Cellular Therapy
|
October 17, 2024
A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients
Jean Roy, Sandra Cohen, Guy Sauvageau, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Plos One
|
April 5, 2018
Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells
Thomas Del'Guidice, Jean-Pascal Lepetit-Stoffaes, Louis-Jean Bordeleau, et al.
European Journal of Haematology
|
August 5, 2020
Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors
Jean-Sébastien Claveau, Sandra Cohen, Imran Ahmad, et al.
Leukemia
|
February 13, 2020
ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia
Denis Claude Roy, Irwin Walker, Johan Maertens, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2024
A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant
Richard LeBlanc, Stéphanie Thiant, Rafik Terra, et al.
Plos Medicine
|
March 24, 2007
Prediction of graft-versus-host disease in humans by donor gene-expression profiling
Chantal Baron, Roland Somogyi, Larry D Greller, et al.
Coronary Artery Disease
|
September 5, 2015
Impact of intracoronary injection of CD133+ bone marrow stem cells on coronary atherosclerotic progression in patients with STEMI: a COMPARE-AMI IVUS substudy
Fuyu Qiu, Akiko Maehara, Ramez El Khoury, et al.
Bone Marrow Transplantation
|
June 9, 2026
Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy
Stéphanie Thiant, Simon Dufresne, Imran Ahmad, et al.
Blood Advances
|
July 19, 2023
Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence
Sandra Cohen, Nadia Bambace, Imran Ahmad, et al.
British Journal of Haematology
|
May 29, 2019
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis
Denis Claude Roy, Sylvie Lachance, Sandra Cohen, et al.
Transplantation and Cellular Therapy
|
October 17, 2024
A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients
Jean Roy, Sandra Cohen, Guy Sauvageau, et al.
Page
of 8